[Effects of lamivudine and interferon-alpha combination therapy on chronic hepatitis B].
Tang
Yujing
Y
Department of Infectious Diseases, Xiamen Traditional Chinese Medicine Hospital, Xiamen 361001, China.
Chen
Guoliang
G
Zheng
Ruidan
R
D000328:Adult; D000914:Antibodies, Viral / Q000097:blood / Q000187:drug effects; D000998:Antiviral Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000097:blood / Q000187:drug effects; D004359:Drug Therapy, Combination; D005260:Female; D006513:Hepatitis B e Antigens / Q000097:blood / Q000187:drug effects; D006515:Hepatitis B virus / Q000187:drug effects* / Q000235:genetics / Q000276:immunology; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000821:virology*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D013997:Time Factors; D016896:Treatment Outcome
D000914:Antibodies, Viral; D000998:Antiviral Agents; D004279:DNA, Viral; D006513:Hepatitis B e Antigens; D016898:Interferon-alpha; D019259:Lamivudine